Neuro-respiratory low-motion events (central apnea) are life threatening, responsible for 100,000 deaths annually across the US and UK*.
Intuitive and attainable consumer products focused on user experience while leveraging novel affordable technology.
Commercial roadmap lead by a targeted US clinic launch in 2026.